Pfizer

BESPONSA

Manufacturer:

Pfizer

Besponsa HCPCS:

J9229

HCPCS Code Descriptor:

Injection, inotuzumab ozogamicin, 0.1 mg

Category:

J Code

Besponsa NDCs:

00008-0100-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Besponsa:

BESPONSA is an Oncology drug manufactured by Pfizer and administered via the Intravenous route of administration. The J Code: J9229 is aligned to the drug BESPONSA.

ACCESS PRICING AND MORE BY REGISTERING

J9229 Added Date:

January 1, 2019

J9229 Effective Date:

January 1, 2019

J9229 Termination Date:

HCPCS Active

Besponsa billing and coding information can be found through Pfizer at the link below:
Besponsa patient assistance information can be found through Pfizer Rx Pathways at the URL: https://www.pfizerrxpathways.com/
BESPONSA prescribing information can be found at the link below:
Information regarding BESPONSA’s side effects can be found at MedlinePlus